Cybin Restructures Staff As It Enters Clinical-Stage Era: Here’s How The Market Responded
Cybin Inc. (NEO:CYBN) (AMEX:CYBN) announced Thursday a streamlining plan aimed at maximizing the company’s operating efficiency and allowing it to focus on critical clinical trials.